<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="26" left="55" width="517" height="27" font="0"><b>ENCODE DCC Antibody Validation Document</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="601" left="238" width="188" height="12" font="1">http://www.rndsystems.com/product_results</text>
<text top="613" left="238" width="67" height="12" font="1">.aspx?k=AF4185</text>
<text top="77" left="138" width="38" height="12" font="1">12/31/11</text>
<text top="340" left="95" width="446" height="12" font="1">Produced in a goat immunized with purified, E. coli-derived, recombinant human Mxi1 (rhMxi1; aa 81 - 228; </text>
<text top="352" left="95" width="417" height="12" font="1">Accession # P50539). Human Mxi1 specific IgG was purified by human Mxi1 affinity chromatography.</text>
<text top="484" left="150" width="31" height="12" font="1">Human</text>
<text top="520" left="178" width="89" height="12" font="2">Immunoprecipitation</text>
<text top="134" left="326" width="92" height="12" font="1">sglandt@stanford.edu</text>
<text top="134" left="83" width="61" height="12" font="1">Stephen Landt</text>
<text top="214" left="121" width="113" height="12" font="1">Anti-human Mxi1 Antibody</text>
<text top="214" left="339" width="108" height="12" font="1">Mxi1 (EntrezGeneID 4601)</text>
<text top="170" left="230" width="29" height="12" font="1">Snyder</text>
<text top="255" left="239" width="54" height="12" font="1">R&amp;D Systems</text>
<text top="484" left="361" width="22" height="12" font="1">Goat </text>
<text top="300" left="395" width="48" height="12" font="1">ZIJ0107031</text>
<text top="300" left="215" width="32" height="12" font="1">AF4185</text>
<text top="520" left="395" width="54" height="12" font="2">IP-Mass Spec</text>
<text top="561" left="141" width="30" height="12" font="2">Affinity</text>
<text top="561" left="356" width="43" height="12" font="2">Polyclonal</text>
<text top="412" left="95" width="409" height="12" font="1">Mxi-1 (Max interactor 1) is a 26 kDa member of the bHLH-leucine zipper family, Myc superfamily of </text>
<text top="424" left="95" width="436" height="12" font="1">transcription factors. It is a widely expressed transcriptional repressor that heterodimerizes with Max and </text>
<text top="436" left="95" width="441" height="12" font="1">blocks Max-Myc gene activation. Human Mxi-1 is 228 amino acids (aa) in length. It contains a DNA binding </text>
<text top="448" left="95" width="429" height="12" font="1">motif (aa 69 - 80) and a bHLH domain (aa 81 - 120). Over aa 81 - 228, human Mxi-1 is 95% aa identical to </text>
<text top="460" left="95" width="56" height="12" font="1">mouse Mxi-1.</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="43" left="125" width="413" height="12" font="1">Comment: We observe one major band of ~40kD in all cell lines assayed, along with bands of lesser </text>
<text top="55" left="125" width="427" height="12" font="1">intensity at ~50kD and ~32kD (Panel A).  The 40kD band is immunoprecipitated from K562 cells at very </text>
<text top="67" left="125" width="426" height="12" font="1">high efficiency, while the 50kD  band is not immunoprecipitated, and the 32kD is immunoprecipitated </text>
<text top="79" left="125" width="433" height="12" font="1">but is present at variable levels and is always at relatively low abundance (Panel B and second validation </text>
<text top="91" left="125" width="429" height="12" font="1">assay).   The major band migrates somewhat slower than predicted for MXI1 (~26kD), but the band was </text>
<text top="103" left="125" width="411" height="12" font="1">confirmed to contain MXI1 by mass spectrometry (see second validation assay).  Therefore, AF4185 </text>
<text top="115" left="125" width="142" height="12" font="1">meets this criterion for validation. </text>
</page>
<page number="3" position="absolute" top="0" left="0" height="612" width="792">
	<fontspec id="3" size="22" family="Times" color="#000000"/>
	<fontspec id="4" size="8" family="Times" color="#000000"/>
	<fontspec id="5" size="10" family="Times" color="#000000"/>
<text top="65" left="137" width="523" height="27" font="3">AF4185 (MXI1) Immunoblot/immunoprecipitation </text>
<text top="93" left="137" width="7" height="27" font="3"> </text>
<text top="246" left="542" width="8" height="11" font="1">3 </text>
<text top="246" left="475" width="28" height="11" font="1">Lane: </text>
<text top="118" left="475" width="42" height="11" font="1">MW (kD) </text>
<text top="154" left="482" width="19" height="11" font="1">100 </text>
<text top="168" left="485" width="14" height="11" font="1">75 </text>
<text top="189" left="485" width="14" height="11" font="1">50 </text>
<text top="202" left="485" width="14" height="11" font="1">38 </text>
<text top="139" left="482" width="19" height="11" font="1">150 </text>
<text top="221" left="485" width="14" height="11" font="1">25 </text>
<text top="246" left="508" width="26" height="11" font="1">1  2 </text>
<text top="246" left="570" width="8" height="11" font="1">4 </text>
<text top="119" left="400" width="29" height="27" font="3">B. </text>
<text top="272" left="83" width="629" height="11" font="4"><b>A.</b>  Western blot using AF4185. Lanes contain nuclear lysates from HeLa S3 cells (Lane 1), K562 cells (Lane 2), GM12878 cells (Lane 3), and </text>
<text top="284" left="83" width="639" height="11" font="1">HepG2 cells (Lane 4).   <b>B.  </b>Immunoprecipitation of MXI1 from K562 cells using AF4185.  Lane 1: input nuclear lysate, Lane 2:  unbound material </text>
<text top="296" left="83" width="649" height="11" font="1">from immunoprecipitation with AF4185, Lane 3: material immunoprecipitated with AF4185, Lane 4: material immunoprecipitated using control IgG.  </text>
<text top="240" left="199" width="95" height="11" font="1">Lane     1     2    3    4</text>
<text top="238" left="293" width="7" height="13" font="5"><b>  </b></text>
<text top="149" left="219" width="19" height="11" font="1">100 </text>
<text top="163" left="222" width="14" height="11" font="1">75 </text>
<text top="180" left="222" width="14" height="11" font="1">50 </text>
<text top="197" left="222" width="14" height="11" font="1">38 </text>
<text top="134" left="219" width="19" height="11" font="1">150 </text>
<text top="213" left="222" width="14" height="11" font="1">25 </text>
<text top="118" left="215" width="42" height="11" font="1">MW (kD) </text>
<text top="119" left="179" width="29" height="27" font="3">A. </text>
</page>
<page number="4" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="698" left="268" width="68" height="10" font="1">Submit by Email</text>
<text top="43" left="130" width="397" height="12" font="1">Immunoprecipitation of MXI from K562 cells using AF4185.  Lane 1: input nuclear lysate, Lane 2: </text>
<text top="55" left="130" width="420" height="12" font="1">material immunoprecipitated with ab87525, Lane 3: material immunoprecipitated using control IgG.  </text>
<text top="67" left="130" width="328" height="12" font="1">Band A was excised from the gel and subject to analysis by mass spectrometry. </text>
<text top="79" left="130" width="2" height="12" font="1"> </text>
<text top="91" left="130" width="403" height="12" font="1">IP followed by mass spectrometry: Briefly, protein was immunoprecipitated from K562 whole cell </text>
<text top="103" left="130" width="412" height="12" font="1">lysates using AF4185, and the IP fraction was loaded on a 10% polyacrylamide gel (NuPAGE Bis-Tris </text>
<text top="115" left="130" width="422" height="12" font="1">Gel) and separated with an Invitrogen NuPAGE electrophoresis system. The gel was silver-stained, gel </text>
<text top="127" left="130" width="411" height="12" font="1">fragments corresponding to the bands indicated were excised and destained using the SilverSNAP </text>
<text top="139" left="130" width="425" height="12" font="1">Stain for Mass Spectrometry (Pierce). Then proteins were trysinized using the in-gel digestion method. </text>
<text top="152" left="130" width="414" height="12" font="1">Digested proteins were analyzed on an LTQ-Orbitrap (Thermo Scientific) by the  nanoLC-ESI-MS/MS </text>
<text top="164" left="130" width="411" height="12" font="1">technique. Peptides were identified by  the SEQUEST algorithm and filtered with a high confidence </text>
<text top="176" left="130" width="327" height="12" font="1">threshold (Protein false discovery rate &lt; 1%, 2 peptides per protein minimum). </text>
<text top="188" left="130" width="2" height="12" font="1"> </text>
<text top="200" left="130" width="384" height="12" font="1">We report 32 proteins identified in band A, although 28 of these are also present in a control </text>
<text top="212" left="130" width="424" height="12" font="1">immunoprecipitation and are thus likely to present due to non-specific association with the IP matrix.  </text>
<text top="224" left="130" width="359" height="12" font="1">Of the remaining proteins, MXI1 is the most abundant (16 peptides) by a wide margin. </text>
<text top="236" left="130" width="2" height="12" font="1"> </text>
<text top="248" left="130" width="406" height="12" font="1">Based on these observations, all major bands are likely due to the presence of immunoprecipated </text>
<text top="260" left="130" width="322" height="12" font="1">MXI1 and AF4185 meets the ENCODE standard for validation by this criterion. </text>
</page>
<page number="5" position="absolute" top="0" left="0" height="612" width="792">
	<fontspec id="6" size="26" family="Times" color="#000000"/>
	<fontspec id="7" size="14" family="Times" color="#000000"/>
	<fontspec id="8" size="12" family="Times" color="#000000"/>
	<fontspec id="9" size="10" family="Times" color="#000000"/>
	<fontspec id="10" size="14" family="Times" color="#000000"/>
<text top="112" left="48" width="84" height="27" font="3">AF4185</text>
<text top="108" left="132" width="596" height="31" font="6"> (MXI1) Immunoprecipitation/Mass spectrometry</text>
<text top="112" left="728" width="7" height="27" font="3"> </text>
<text top="141" left="48" width="7" height="27" font="3"> </text>
<text top="179" left="237" width="100" height="20" font="7">MXI1(AF4185)  </text>
<text top="184" left="186" width="21" height="15" font="5"><b>MW</b></text>
<text top="180" left="207" width="4" height="20" font="7"> </text>
<text top="212" left="185" width="23" height="13" font="5"><b>250 </b></text>
<text top="240" left="185" width="23" height="13" font="5"><b>150 </b></text>
<text top="261" left="185" width="23" height="13" font="5"><b>100 </b></text>
<text top="281" left="188" width="17" height="13" font="5"><b>75 </b></text>
<text top="308" left="188" width="17" height="13" font="5"><b>50 </b></text>
<text top="331" left="188" width="17" height="13" font="5"><b>37 </b></text>
<text top="355" left="188" width="17" height="13" font="5"><b>25 </b></text>
<text top="393" left="188" width="17" height="13" font="5"><b>10 </b></text>
<text top="421" left="161" width="35" height="16" font="8">Lane </text>
<text top="421" left="231" width="121" height="16" font="8">1              2           3</text>
<text top="419" left="352" width="4" height="20" font="7"> </text>
<text top="208" left="403" width="105" height="13" font="9">Lane 1 Input lysate </text>
<text top="222" left="403" width="166" height="13" font="9">Lane 2 Bound material from IP </text>
<text top="236" left="403" width="203" height="13" font="9">Lane 3 Bound material from IP            </text>
<text top="251" left="443" width="119" height="13" font="9">using non-specific IgG</text>
<text top="246" left="562" width="4" height="20" font="7"> </text>
<text top="333" left="376" width="42" height="13" font="5"><b>Band A</b></text>
<text top="329" left="418" width="4" height="18" font="10"><b> </b></text>
</page>
<page number="6" position="absolute" top="0" left="0" height="612" width="792">
<text top="81" left="250" width="73" height="11" font="1">Name of Protein</text>
<text top="75" left="483" width="37" height="11" font="1">Peptide </text>
<text top="87" left="487" width="27" height="11" font="1">Count</text>
<text top="73" left="528" width="91" height="12" font="1">Ratio (MXI1/          IgG </text>
<text top="87" left="556" width="33" height="12" font="1">Control)</text>
<text top="101" left="59" width="32" height="12" font="1">Band A</text>
<text top="102" left="249" width="75" height="11" font="1">MAX interactor 1</text>
<text top="102" left="494" width="11" height="11" font="1">16</text>
<text top="101" left="532" width="81" height="12" font="1">NOT IN CONTROL IP</text>
<text top="115" left="59" width="32" height="12" font="1">Band A</text>
<text top="115" left="199" width="175" height="11" font="1">Isoform 1 of Core histone macro-H2A.1</text>
<text top="115" left="494" width="11" height="11" font="1">16</text>
<text top="115" left="563" width="20" height="11" font="1">0.89</text>
<text top="128" left="59" width="32" height="12" font="1">Band A</text>
<text top="128" left="151" width="271" height="11" font="1">Isoform A1-A of Heterogeneous nuclear ribonucleoprotein A1</text>
<text top="128" left="494" width="11" height="11" font="1">16</text>
<text top="128" left="563" width="20" height="11" font="1">0.89</text>
<text top="141" left="59" width="32" height="12" font="1">Band A</text>
<text top="141" left="111" width="351" height="11" font="1">cDNA FLJ59080, highly similar to Heterogeneous nuclear ribonucleoprotein A3</text>
<text top="141" left="494" width="11" height="11" font="1">15</text>
<text top="141" left="563" width="20" height="11" font="1">1.07</text>
<text top="165" left="59" width="32" height="12" font="1">Band A</text>
<text top="154" left="100" width="376" height="11" font="1">cDNA FLJ77422, highly similar to Homo sapiens RNA binding protein, autoantigenic </text>
<text top="166" left="100" width="376" height="11" font="1">(hnRNP-associated with lethal yellow homolog (mouse)), transcript variant 1, mRNA </text>
<text top="178" left="262" width="50" height="11" font="1">(Fragment)</text>
<text top="166" left="494" width="11" height="11" font="1">14</text>
<text top="166" left="563" width="20" height="11" font="1">1.17</text>
<text top="190" left="59" width="32" height="12" font="1">Band A</text>
<text top="190" left="224" width="125" height="11" font="1">Isoform 2 of Nucleophosmin</text>
<text top="190" left="494" width="11" height="11" font="1">13</text>
<text top="190" left="563" width="20" height="11" font="1">1.30</text>
<text top="203" left="59" width="32" height="12" font="1">Band A</text>
<text top="203" left="244" width="85" height="11" font="1">ELAV-like protein 1</text>
<text top="203" left="494" width="11" height="11" font="1">10</text>
<text top="203" left="563" width="20" height="11" font="1">2.00</text>
<text top="216" left="59" width="32" height="12" font="1">Band A</text>
<text top="216" left="188" width="196" height="11" font="1">Putative uncharacterized protein HNRNPAB</text>
<text top="216" left="494" width="11" height="11" font="1">10</text>
<text top="216" left="563" width="20" height="11" font="1">1.67</text>
<text top="228" left="59" width="32" height="12" font="1">Band A</text>
<text top="229" left="202" width="169" height="11" font="1">rRNA 2'-O-methyltransferase fibrillarin</text>
<text top="229" left="494" width="11" height="11" font="1">10</text>
<text top="229" left="563" width="19" height="11" font="1">1.11</text>
<text top="241" left="59" width="32" height="12" font="1">Band A</text>
<text top="242" left="209" width="154" height="11" font="1">Serine/threonine-protein kinase 12</text>
<text top="242" left="497" width="6" height="11" font="1">9</text>
<text top="242" left="563" width="20" height="11" font="1">4.50</text>
<text top="254" left="59" width="32" height="12" font="1">Band A</text>
<text top="255" left="158" width="257" height="11" font="1">Isoform 3 of Heterogeneous nuclear ribonucleoprotein H3</text>
<text top="255" left="497" width="6" height="11" font="1">9</text>
<text top="255" left="563" width="20" height="11" font="1">0.90</text>
<text top="267" left="59" width="32" height="12" font="1">Band A</text>
<text top="268" left="160" width="253" height="11" font="1">MKI67 FHA domain-interacting nucleolar phosphoprotein</text>
<text top="268" left="497" width="6" height="11" font="1">6</text>
<text top="268" left="563" width="20" height="11" font="1">0.86</text>
<text top="280" left="59" width="32" height="12" font="1">Band A</text>
<text top="281" left="236" width="100" height="11" font="1">Isoform 1 of Serpin B3</text>
<text top="281" left="497" width="6" height="11" font="1">5</text>
<text top="281" left="563" width="20" height="11" font="1">2.50</text>
<text top="293" left="59" width="32" height="12" font="1">Band A</text>
<text top="294" left="178" width="217" height="11" font="1">Isoform 3 of Transformer-2 protein homolog beta</text>
<text top="294" left="497" width="6" height="11" font="1">5</text>
<text top="294" left="563" width="20" height="11" font="1">1.67</text>
<text top="306" left="59" width="32" height="12" font="1">Band A</text>
<text top="307" left="229" width="115" height="11" font="1">Poly(rC)-binding protein 1</text>
<text top="307" left="497" width="6" height="11" font="1">4</text>
<text top="307" left="563" width="20" height="11" font="1">1.33</text>
<text top="319" left="59" width="32" height="12" font="1">Band A</text>
<text top="320" left="231" width="110" height="11" font="1">Brix domain containing 1</text>
<text top="320" left="497" width="6" height="11" font="1">4</text>
<text top="320" left="563" width="20" height="11" font="1">0.80</text>
<text top="332" left="59" width="32" height="12" font="1">Band A</text>
<text top="333" left="175" width="224" height="11" font="1">U5 small nuclear ribonucleoprotein 40 kDa protein</text>
<text top="333" left="497" width="6" height="11" font="1">4</text>
<text top="333" left="563" width="20" height="11" font="1">0.80</text>
<text top="345" left="59" width="32" height="12" font="1">Band A</text>
<text top="346" left="152" width="269" height="11" font="1">Isoform 3 of Heterogeneous nuclear ribonucleoprotein D-like</text>
<text top="346" left="497" width="6" height="11" font="1">4</text>
<text top="346" left="563" width="20" height="11" font="1">0.67</text>
<text top="359" left="59" width="32" height="12" font="1">Band A</text>
<text top="359" left="210" width="152" height="11" font="1">elongation factor 1-delta isoform 4</text>
<text top="359" left="497" width="6" height="11" font="1">3</text>
<text top="358" left="532" width="81" height="12" font="1">NOT IN CONTROL IP</text>
<text top="372" left="59" width="32" height="12" font="1">Band A</text>
<text top="372" left="257" width="58" height="11" font="1">Histone H1.5</text>
<text top="372" left="497" width="6" height="11" font="1">3</text>
<text top="372" left="563" width="20" height="11" font="1">1.50</text>
<text top="385" left="59" width="32" height="12" font="1">Band A</text>
<text top="385" left="186" width="202" height="11" font="1">cDNA FLJ59138, highly similar to Annexin A2</text>
<text top="385" left="497" width="6" height="11" font="1">3</text>
<text top="385" left="563" width="20" height="11" font="1">1.00</text>
<text top="398" left="59" width="32" height="12" font="1">Band A</text>
<text top="398" left="187" width="199" height="11" font="1">Heterogeneous nuclear ribonucleoprotein A0</text>
<text top="398" left="497" width="6" height="11" font="1">3</text>
<text top="398" left="563" width="20" height="11" font="1">1.00</text>
<text top="411" left="59" width="32" height="12" font="1">Band A</text>
<text top="411" left="182" width="209" height="11" font="1">RNA 3'-terminal phosphate cyclase-like protein</text>
<text top="411" left="497" width="6" height="11" font="1">3</text>
<text top="411" left="563" width="20" height="11" font="1">0.75</text>
<text top="424" left="59" width="32" height="12" font="1">Band A</text>
<text top="424" left="229" width="114" height="11" font="1">Zinc-alpha-2-glycoprotein</text>
<text top="424" left="497" width="6" height="11" font="1">3</text>
<text top="424" left="563" width="20" height="11" font="1">0.75</text>
<text top="437" left="59" width="32" height="12" font="1">Band A</text>
<text top="437" left="153" width="266" height="11" font="1">cDNA FLJ54752, highly similar to Poly(rC)-binding protein 2</text>
<text top="437" left="497" width="6" height="11" font="1">3</text>
<text top="437" left="563" width="20" height="11" font="1">0.43</text>
<text top="450" left="59" width="32" height="12" font="1">Band A</text>
<text top="451" left="234" width="104" height="11" font="1">Isoform 1 of Arginase-1</text>
<text top="451" left="497" width="6" height="11" font="1">2</text>
<text top="450" left="532" width="81" height="12" font="1">NOT IN CONTROL IP</text>
<text top="464" left="59" width="32" height="12" font="1">Band A</text>
<text top="465" left="203" width="167" height="11" font="1">Isoform 2 of Zinc finger protein Gfi-1b</text>
<text top="465" left="497" width="6" height="11" font="1">2</text>
<text top="464" left="532" width="81" height="12" font="1">NOT IN CONTROL IP</text>
<text top="478" left="59" width="32" height="12" font="1">Band A</text>
<text top="478" left="231" width="110" height="11" font="1">Isoform 2 of Neuroguidin</text>
<text top="478" left="497" width="6" height="11" font="1">2</text>
<text top="478" left="563" width="20" height="11" font="1">2.00</text>
<text top="491" left="59" width="32" height="12" font="1">Band A</text>
<text top="491" left="201" width="171" height="11" font="1">Putative uncharacterized protein IMP4</text>
<text top="491" left="497" width="6" height="11" font="1">2</text>
<text top="491" left="563" width="20" height="11" font="1">2.00</text>
<text top="504" left="59" width="32" height="12" font="1">Band A</text>
<text top="504" left="221" width="131" height="11" font="1">SYNCRIP protein (Fragment)</text>
<text top="504" left="497" width="6" height="11" font="1">2</text>
<text top="504" left="563" width="20" height="11" font="1">0.67</text>
<text top="516" left="59" width="32" height="12" font="1">Band A</text>
<text top="517" left="232" width="109" height="11" font="1">Protein MAK16 homolog</text>
<text top="517" left="497" width="6" height="11" font="1">2</text>
<text top="517" left="563" width="20" height="11" font="1">0.50</text>
</page>
<page number="7" position="absolute" top="0" left="0" height="612" width="792">
<text top="73" left="59" width="32" height="12" font="1">Band A</text>
<text top="73" left="195" width="182" height="11" font="1">Probable rRNA-processing protein EBP2</text>
<text top="73" left="497" width="6" height="11" font="1">2</text>
<text top="73" left="563" width="20" height="11" font="1">0.40</text>
</page>
</pdf2xml>
